These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23115117)

  • 1. An extreme example of focal bone marrow involvement in acute myeloid leukemia.
    Brierley CK; Morgan EA; Sprague JR; Odejide OO; DeAngelo DJ; Steensma DP
    Am J Hematol; 2013 Apr; 88(4):335-6. PubMed ID: 23115117
    [No Abstract]   [Full Text] [Related]  

  • 2. An unusual initial manifestation of acute leukemia.
    Desai A; Desai A; Staszewski H; Cunha BA
    Am J Med; 2012 Dec; 125(12):1173-4. PubMed ID: 23062401
    [No Abstract]   [Full Text] [Related]  

  • 3. Is a nadir bone marrow required and, if so, what to do with residual disease?
    Luger SM
    Best Pract Res Clin Haematol; 2011 Dec; 24(4):527-32. PubMed ID: 22127316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse of acute myeloid leukemia as isolated bilateral testicular granulocytic sarcoma in an adult.
    Ghadiany M; Attarian H; Hajifathali A; Khosravi A; Molanaee S
    Urol J; 2008; 5(2):132-4; discussion 134-5. PubMed ID: 18592470
    [No Abstract]   [Full Text] [Related]  

  • 5. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
    Zittoun RA; Mandelli F; Willemze R; de Witte T; Labar B; Resegotti L; Leoni F; Damasio E; Visani G; Papa G
    N Engl J Med; 1995 Jan; 332(4):217-23. PubMed ID: 7808487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
    Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
    Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment marrow cytogenetic status: a predictor of response to remission induction therapy in acute myelogenous leukemia.
    Conjalka MS; Cuttner J; Wisniewski L; Goldberg JD; Reisman A; Elliott R; Desnick R; Holland JF; Berk PD
    Mt Sinai J Med; 1983; 50(3):201-7. PubMed ID: 6604864
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bone marrow changes in acute non-lymphocytic leukemia patients treated with low-dose Ara-C--implications of therapeutic mechanism].
    Lin SF; Liu HW; Chen JR; Chien CH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Sep; 3(9):612-7. PubMed ID: 3483023
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences in the induction of remission and in maintenance therapy in acute myeloblastic leukemia in adults with the RAMPO scheme].
    Höche D; Herold M; Fink R; Anger G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):237-43. PubMed ID: 6168533
    [No Abstract]   [Full Text] [Related]  

  • 10. Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission.
    Lee SH; Abebe L; Paietta E; Einzig A; Wiernik PH
    Am J Hematol; 2009 Jul; 84(7):455-7. PubMed ID: 19507211
    [No Abstract]   [Full Text] [Related]  

  • 11. [Basophilic acute leukemias (author's transl)].
    Quattrin N
    Nouv Rev Fr Hematol; 1973; 13(6):745-54. PubMed ID: 4280040
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognosis of acute leukaemia in adults.
    Penington DG; Keating MJ
    Med J Aust; 1974 Jun; 1(26):1031-5. PubMed ID: 4527947
    [No Abstract]   [Full Text] [Related]  

  • 13. [Letter: New combination drug therapy of acute myeloid leukemia].
    Fière D; Bryon PA; Martin C; Péaud PY
    Nouv Presse Med; 1975 Sep; 4(29):2114 (1). PubMed ID: 1058467
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of acute myeloid leukemia in adults with a combination of daunomycin and cytosine-arabinoside].
    Brincker H
    Ugeskr Laeger; 1972 Oct; 134(42):2195-200. PubMed ID: 4563112
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of myeloblastic leukemia after 65 years. Results in 9 cases].
    Guy H; Besancenot JF; Cortet P; Baudet D; Schadeck C; Bonhomme J
    Nouv Presse Med; 1979 Mar; 8(10):780. PubMed ID: 288026
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-1 beta expression and treatment outcome in acute myelogenous leukemia.
    Preisler HD; Raza A; Kukla C; Larson R; Goldberg J; Browman G
    Blood; 1991 Aug; 78(3):849-50. PubMed ID: 1859896
    [No Abstract]   [Full Text] [Related]  

  • 17. Short induction treatment in acute granulocytic leukemia.
    Fiere D; Bryon PA; Martin C; Revol L
    Biomedicine; 1975 Sep; 23(7):279-82. PubMed ID: 1085172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of refractory undifferentiated acute myelogenous leukemia with all-trans-retinoic acid.
    Griggs JJ; Henley SE; Rowe JM
    Am J Hematol; 1994 Feb; 45(2):177-80. PubMed ID: 8141124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the treatment of acute myelogenous leukemia.
    Gale RP
    N Engl J Med; 1979 May; 300(21):1189-99. PubMed ID: 372809
    [No Abstract]   [Full Text] [Related]  

  • 20. The disappearance of ring sideroblasts in myeloblastic leukaemia in remission.
    Shaw MT; Foadi M
    Scand J Haematol; 1971; 8(3):177-9. PubMed ID: 5285822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.